Cochlear | COH - Gross Profit On Sales

Stock Price
173.63
Daily Change
-3.35 -1.89%
Monthly
-4.87%
Yearly
-32.38%
Q2 Forecast
168.62

Cochlear reported AUD856.8M in Gross Profit on Sales for its fiscal semester ending in December of 2025.





Gross Profit On Sales Change Date
Ansell USD 326.2M 27.6M Jun/2024
Avita Medical AUD 14.31M 639K Dec/2025
Cochlear AUD 856.8M 430M Dec/2025
CSL USD 4.46B 2.71B Dec/2025
Fisher Paykel Healthcare NZD 685.7M 3.5M Dec/2025
Healius AUD 554.4M 415.55M Dec/2024
Integral Diagnostics AUD 226.91M 7.04M Jun/2024
Mayne Pharma AUD 86.13M 18.92M Jun/2025
Mesoblast USD 3.16M 9.61M Dec/2024
Monash IVF AUD 110.44M 89.18M Dec/2025
Nanosonics AUD 78.01M 3.95M Dec/2025
Polynovo AUD 61.26M 38M Dec/2025
Ramsay Health Care AUD 549.95M 5.77B Jun/2025
Regis Healthcare AUD 47.9M 43.33M Jun/2025
ResMed USD 886.53M 65.71M Dec/2025
Sigma Healthcare AUD 160.13M 10.55M Jul/2024
Somnomed AUD 26.76M 1.59M Jun/2023
Sonic Healthcare AUD 3.92B 3.14B Dec/2024
Telix Pharmaceuticals AUD 217.82M 9.23M Dec/2025